Konya, Viktoria <br/><br/>
Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors.  [electronic resource] 

 -  European journal of immunology  Aug 2011 
 - 2379-89 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-4141 
<br/><br/><label>Standard No.: </label>10.1002/eji.201141460  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD18 Antigens--metabolism<br/>Cell Adhesion--drug effects<br/>Cell Communication<br/>Cell Line<br/>Cell Movement--drug effects<br/>Cells, Cultured<br/>Chemokine CCL11--pharmacology<br/>Cyclopentanes--pharmacology<br/>Dinoprostone--pharmacology<br/>Endothelial Cells--cytology<br/>Eosinophils--cytology<br/>Fibronectins--metabolism<br/>Flow Cytometry<br/>Gelsolin--metabolism<br/>Humans<br/>L-Selectin--metabolism<br/>Methyl Ethers<br/>Microscopy, Confocal<br/>Naphthalenes--pharmacology<br/>Phenylbutyrates--pharmacology<br/>Receptors, Prostaglandin E, EP1 Subtype--metabolism<br/>Receptors, Prostaglandin E, EP2 Subtype--metabolism<br/>Receptors, Prostaglandin E, EP3 Subtype--metabolism<br/>Receptors, Prostaglandin E, EP4 Subtype--agonists<br/>Thioglycolates--pharmacology<br/>Thrombin--pharmacology<br/>Tumor Necrosis Factor-alpha--pharmacology